World Lung Foundation

World Lung Foundation
Name	World Lung Foundation
Type	Nonprofit organization
Founded	2004
Headquarters	New York City
Area served	Global
Focus	Respiratory health, tobacco control, air quality, infectious disease

World Lung Foundation

The World Lung Foundation is an international nonprofit organization focused on reducing the global burden of respiratory disease through public health programs, policy advocacy, and capacity building. It operates across multiple regions working with national ministries of health ministries, multilateral agencies such as the World Health Organization, bilateral donors including the United States Agency for International Development, and philanthropic institutions like the Bill & Melinda Gates Foundation. The foundation has implemented projects in collaboration with city governments, academic centers, and technical partners including Johns Hopkins University, Imperial College London, and Harvard T.H. Chan School of Public Health.

History

The organization was established in 2004 amid heightened global attention to tobacco control and pandemics following events such as the 2003 Severe Acute Respiratory Syndrome outbreak and the 2005 revisions to the International Health Regulations. Early initiatives aligned with the adoption of the WHO Framework Convention on Tobacco Control and the scaling-up of DOTS and Stop TB Partnership activities. In its formative years the foundation partnered with agencies active in global health, including UNAIDS, UNITAID, and the Global Fund to Fight AIDS, Tuberculosis and Malaria, while commissioning research from institutions such as the London School of Hygiene & Tropical Medicine and the University of Cape Town. Over time it expanded from tobacco control to air pollution mitigation, pediatric pneumonia programs influenced by Integrated Management of Childhood Illness approaches, and pandemic preparedness following experiences with H1N1 influenza and Ebola virus epidemic in West Africa responses.

Mission and Objectives

The stated mission centers on reducing death and disease from respiratory conditions by advancing tobacco cessation, improving air quality, strengthening diagnostics and treatment for tuberculosis, and promoting vaccination strategies like those for pneumococcal vaccine and influenza vaccine. Objectives include influencing policy at forums such as the World Health Assembly, supporting national implementation of Framework Convention on Tobacco Control articles, and enhancing clinical capacity in settings partnered with Centers for Disease Control and Prevention programs. The foundation articulates goals consistent with the Sustainable Development Goals, particularly targets related to child health and non-communicable diseases championed by agencies like the United Nations.

Programs and Initiatives

Programs have encompassed tobacco control campaigns modeled on efforts seen in Australia and Canada, air quality monitoring projects akin to work by European Environment Agency, and community case management interventions paralleling initiatives by Médecins Sans Frontières. Notable initiatives included tobacco cessation training with academic partners such as Columbia University, pilot air pollution interventions in megacities comparable to projects in Beijing and Delhi, and tuberculosis diagnostic strengthening aligned with GeneXpert deployment strategies promoted by FIND (Foundation for Innovative New Diagnostics). The foundation also supported advocacy coalitions reminiscent of Campaign for Tobacco-Free Kids campaigns and contributed to capacity building in laboratories partnering with networks like the Global Laboratory Initiative.

Partnerships and Funding

Funding sources have included public donors such as United States Department of Health and Human Services, multilateral financiers like World Bank projects, and private philanthropies including the Bloomberg Philanthropies and the Rockefeller Foundation. Operational partnerships have been forged with national bodies such as the Ministry of Health (India), city administrations like New York City Department of Health and Mental Hygiene, and academic consortia including University College London. Collaborations with international programs have involved PATH, Clinton Health Access Initiative, and technical agencies such as PATHogen Modeling groups and GAVI, the Vaccine Alliance-aligned stakeholders. Grantmaking and project cooperation followed models used by entities like the Wellcome Trust.

Organizational Structure and Governance

The governance framework has featured a board of directors with expertise spanning public health, clinical medicine, and global philanthropy, drawing individuals with backgrounds from institutions such as Harvard Medical School, Yale University, and corporate partners similar to GlaxoSmithKline and Pfizer. Executive leadership coordinated programmatic divisions for tobacco control, air quality, and infectious disease, interfacing with monitoring bodies like the Independent Evaluation Group style mechanisms. Legal and compliance functions were influenced by standards set by registrars in jurisdictions including New York (state) and international nonprofit regulations observed by organizations such as Charity Commission for England and Wales.

Impact and Evaluation

Impact assessments employed epidemiological and implementation research methods used by groups like the Institute for Health Metrics and Evaluation and evaluation frameworks similar to those developed by the International Development Evaluation Association. Reported outcomes included tobacco policy adoption in line with MPOWER measures, strengthened tuberculosis diagnostics and treatment cascade improvements resembling progress tracked by the Stop TB Partnership, and air quality interventions informing municipal policies comparable to changes seen in London and Stockholm. Independent evaluations referenced methodologies from Cochrane Collaboration-style reviews and used data sources including Demographic and Health Surveys and country-level surveillance systems maintained by the European Centre for Disease Prevention and Control.

Category:International medical and health organizations